Cencora (COR) Total Non-Current Liabilities (2009 - 2026)
Cencora (COR) reported Total Non-Current Liabilities of $329.1 million for Q1 2026, up 111.63% on a YoY basis from $155.5 million in Q1 2025, and up 111.02% quarter-over-quarter from -$3.0 billion in Q4 2025.
Cencora (COR) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends
Cencora has reported Total Non-Current Liabilities for 18 years, with the latest figure at $329.1 million in Q1 2026.
- For the quarter ending Q1 2026, Total Non-Current Liabilities rose 111.63% year-over-year to $329.1 million; the trailing twelve-month figure through Mar 2026 stood at $329.1 million (up 111.63% YoY), and the FY2025 full-year result was -$2.9 billion, down 1020.43% from the prior year.
- Total Non-Current Liabilities for Q1 2026 stood at $329.1 million, up from -$3.0 billion in the prior quarter.
- The five-year high for Total Non-Current Liabilities was $329.1 million in Q1 2026, with the low at -$3.0 billion in Q4 2025.
- Historically, Total Non-Current Liabilities has averaged -$725.6 million across 5 years, with a median of $207.3 million in 2022.
- Annual changes were most pronounced in 2022 — Total Non-Current Liabilities surged 203.1% — and 2025, when it tumbled 1207.83%.
- Cencora's Total Non-Current Liabilities stood at -$517.2 million in 2022, then surged by 143.21% to $223.5 million in 2023, then grew by 20.57% to $269.5 million in 2024, then plunged by 1207.83% to -$3.0 billion in 2025, then surged by 111.02% to $329.1 million in 2026.
- The last three Total Non-Current Liabilities figures came in at $329.1 million (Q1 2026), -$3.0 billion (Q4 2025), and -$2.9 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | 1.72 Mn |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | -2.37 Bn |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 329.13 Mn |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | - |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | 6.05 Bn |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | 2.79 Bn |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | 58.52 Mn |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | 279.68 Mn |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | 40.66 Mn |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | 1.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 329.13 Mn |
| Dec 31, 2025 | -2.99 Bn |
| Sep 30, 2025 | -2.95 Bn |
| Jun 30, 2025 | -2.90 Bn |
| Mar 31, 2025 | -2.83 Bn |
| Dec 31, 2024 | 269.47 Mn |
| Sep 30, 2024 | 320.47 Mn |
| Jun 30, 2024 | -1.39 Bn |
| Mar 31, 2024 | -1.37 Bn |
| Dec 31, 2023 | 223.50 Mn |
| Sep 30, 2023 | 271.65 Mn |
| Jun 30, 2023 | 327.50 Mn |
| Mar 31, 2023 | 218.17 Mn |
| Dec 31, 2022 | -517.19 Mn |
| Sep 30, 2022 | 147.18 Mn |
| Jun 30, 2022 | 207.29 Mn |
| Mar 31, 2022 | 287.83 Mn |
| Dec 31, 2021 | 122.96 Mn |
| Sep 30, 2021 | 131.99 Mn |
| Jun 30, 2021 | -586.25 Mn |